poisar

Stocks · News reference

Barclays Maintains Teladoc Health at Equal-Weight and Raises Price Target

Fiscal.ai

Barclays analyst updated their outlook on Teladoc Health, maintaining an Equal-Weight rating while increasing the price target from $7 to $9.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncFn Media

    A $400 Billion Healthcare Opportunity: Telehealth Companies Positioned to Capitalize on a Massive Industry Shift

    The global telehealth market is experiencing significant growth, projected to expand from $77.4 billion in 2025 to $187.5 billion by 2033. Key developments include AI-powered diagnostics, remote patient monitoring, and virtual care expansion. Rocket Doctor AI joined the Altais network to expand telehealth services in California, while competitors like Teladoc Health, Amwell, Hims & Hers, and Doximity launched new AI capabilities and research initiatives to enhance digital healthcare delivery.